Depakote - 54868-5525-1 - (divalproex sodium)

Alphabetical Index


Drug Information of Depakote

Product NDC: 54868-5525
Proprietary Name: Depakote
Non Proprietary Name: divalproex sodium
Active Ingredient(s): 250    mg/1 & nbsp;   divalproex sodium
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Depakote

Product NDC: 54868-5525
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021168
Marketing Category: NDA
Start Marketing Date: 20060210

Package Information of Depakote

Package NDC: 54868-5525-1
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (54868-5525-1)

NDC Information of Depakote

NDC Code 54868-5525-1
Proprietary Name Depakote
Package Description 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (54868-5525-1)
Product NDC 54868-5525
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name divalproex sodium
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20060210
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name DIVALPROEX SODIUM
Strength Number 250
Strength Unit mg/1
Pharmaceutical Classes Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]

Complete Information of Depakote


General Information